Gut mucosal microbiome across stages of colorectal carcinogenesis

Nature Communications

Volumn 6, Issue , 2015, Pages

  Nakatsu, Geicho ^a   Li, Xiangchun ^a   Zhou, Haokui ^a   Sheng, Jianqiu ^b   Wong, Sunny Hei ^a   Wu, William Ka Kai ^a   Ng, Siew Chien ^a   Tsoi, Ho ^a   Dong, Yujuan ^a   Zhang, Ning ^c   He, Yuqi ^b   Kang, Qian ^b   Cao, Lei ^a   Wang, Kunning ^a   Zhang, Jingwan ^a   Liang, Qiaoyi ^a   Yu, Jun ^a   Sung, Joseph J Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; DATA SET; LESION; MICROBIAL COMMUNITY; MUCUS; TAXONOMY; TUMOR;

BACTERIA (MICROORGANISMS);

AGED; BACTERIUM; BIODIVERSITY; CARCINOGENESIS; CASE CONTROL STUDY; CLASSIFICATION; COLORECTAL TUMOR; DYSBIOSIS; FEMALE; GENETICS; HUMAN; INTESTINE FLORA; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY;

AGED; BACTERIA; BIODIVERSITY; CARCINOGENESIS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DYSBIOSIS; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; MALE; MIDDLE AGED;

EID: 84946144999     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9727     Document Type: Article

References (56)

1. Sears, C. L. & Garrett, W. S. Microbes, microbiota, and colon cancer. Cell Host Microbe 15, 317-328 (2014).
2. Zackular, J. P., Rogers, M. A., Ruffin, M. T. 4th & Schloss, P. D. The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev. Res. 7, 1112-1121 (2014).
3. Irrazabal, T., Belcheva, A., Girardin, S. E., Martin, A. & Philpott, D. J. The multifaceted role of the intestinal microbiota in colon cancer. Mol. Cell 54, 309-320 (2014).
4. Belcheva, A. et al. Gut microbial metabolism drives transformation of Msh2-deficient colon epithelial cells. Cell 158, 288-299 (2014).
5. Ijssennagger, N. et al. Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon. Proc. Natl Acad. Sci. USA 112, 10038-10043 (2015).
6. Rubinstein, M. R. et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 14, 195-206 (2013).
7. Kostic, A. D. et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22, 292-298 (2012).
8. Castellarin, M. et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22, 299-306 (2012).
9. Tahara, T. et al. Fusobacterium in colonic flora and molecular features of colorectal carcinoma. Cancer Res. 74, 1311-1318 (2014).
10. Mima, K. et al. Fusobacterium nucleatum and T cells in colorectal carcinoma. JAMA Oncol. 1, 653-661 (2015).
11. Gur, C. et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 42, 382-392 (2015).
12. Warren, R. L. et al. Co-occurrence of anaerobic bacteria in colorectal carcinomas. Microbiome 1, 16 (2013).
13. Geng, J., Fan, H., Tang, X., Zhai, H. & Zhang, Z. Diversified pattern of the human colorectal cancer microbiome. Gut. Pathog. 5, 2 (2013).
14. Chen, W., Liu, F., Ling, Z., Tong, X. & Xiang, C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS ONE 7, e39743 (2012).
15. Ding, T. & Schloss, P. D. Dynamics and associations of microbial community types across the human body. Nature 509, 357-360 (2014).
16. Schloss, P. D. et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75, 7537-7541 (2009).
17. Schloss, P. D., Gevers, D. & Westcott, S. L. Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies. PLoS ONE 6, e27310 (2011).
18. Holmes, I., Harris, K. & Quince, C. Dirichlet multinomial mixtures: generative models for microbial metagenomics. PLoS ONE 7, e30126 (2012).
19. Breiman, L. Random Forests. Mach. Learn. 45, 5-32 (2001).
20. Zeller, G. et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol. Syst. Biol. 10, 766 (2014).
21. Tibshirani, R. Regression selection and shrinkage via the lasso. J. Royal Stat. Soc. B 58, 267-288 (1994).
22. Friedman, J. & Alm, E. J. Inferring correlation networks from genomic survey data. PLoS Comput. Biol. 8, e1002687 (2012).
23. Boleij, A. et al. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin. Infect. Dis. 60, 208-215 (2015).
24. Dejea, C. M. et al. Microbiota organization is a distinct feature of proximal colorectal cancers. Proc. Natl Acad. Sci. USA 111, 18321-18326 (2014).
25. Johnson, C. H. et al. Metabolism links bacterial biofilms and colon carcinogenesis. Cell Metab. 21, 891-897 (2015).
26. Liu, J. et al. Metabolic co-dependence gives rise to collective oscillations within biofilms. Nature 523, 550-554 (2015).
27. Gnagnarellla, P., Gandini, S., La Vecchia, C. & Maisonneuve, P. Glycemic index, glycemic load, and cancer risk: a meta-analysis. Am. J. Clin. Nutr. 87, 1793-1801 (2008).
28. Meyerhardt, J. A. et al. Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J. Natl Cancer Inst. 104, 1702-1711 (2012).
29. Arthur, J. C. et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338, 120-123 (2012).
30. Grivennikov, S. I. et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491, 254-258 (2012).
31. Huber, S. et al. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 491, 259-263 (2012).
32. Couturier-Maillard, A. et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J. Clin. Invest. 123, 700-711 (2013).
33. Cuevas-Ramos, G. et al. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc. Natl Acad. Sci. USA 107, 11537-11542 (2010).
34. Riley D. R. et al. Bacteria-human somatic cell lateral gene transfer is enriched in cancer samples. PLoS Comput. Biol. 9 e1003107 (2013).
35. Maurice, C. F., Haiser, H. J. & Turnbaugh, P. J. Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell 152, 39-50 (2013).
36. Shah, P. & Swiatlo, E. A multifaceted role for polyamines in bacterial pathogens. Mol. Microbiol. 68, 4-16 (2008).
37. Murray, I. A., Patterson, A. D. & Perdew, G. H. Aryl hydrocarbon receptor ligands in cancer: friend and foe. Nat. Rev. Cancer. 14, 801-814 (2014).
38. Royet, J., Gupta, D. & Dziarski, R. Peptidoglycan recognition proteins: modulators of the microbiome and inflammation. Nat. Rev. Immunol. 11, 837-851 (2011).
39. Wu, S. et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med 15, 1016-1022 (2009).
40. Farrell, J. J. et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut. 61, 582-588 (2012).
41. Harrell, L. et al. Standard colonic lavage alters the natural state of mucosalassociated microbiota in the human colon. PLoS ONE 7, e32545 (2012).
42. Wong, M. C. et al. A comparison of the acceptance of immunochemical faecal occult blood test and colonoscopy in colorectal cancer screening: a prospective study among Chinese. Aliment. Pharmacol. Ther. 32, 74-82 (2010).
43. Wong, M. C. et al. A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects. Gut. 63, 1130-1136 (2014).
44. Yeoh, K.-G. et al. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut. 60, 1236-1241 (2011).
45. Yuan, S., Cohen, D. B., Ravel, J., Abdo, Z. & Forney, L. J. Evaluation of methods for the extraction and purification of DNA from the human microbiome. PLoS ONE 7, e33865 (2012).
46. Quince, C., Lanzen, A., Davenport, R. J. & Turnbaugh, P. J. Removing noise from pyrosequenced amplicons. BMC Bioinformatics 12, 38 (2011).
47. Schloss, P. D. A high-throughput DNA sequence aligner for microbial ecology studies. PLoS ONE 4, e8230 (2009).
48. Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C. & Knight, R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27, 2194-2200 (2011).
49. Wang, Q., Garrity, G. M., Tiedje, J. M. & Cole, J. R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73, 5261-5267 (2007).
50. Koren, O. et al. A guide to enterotypes across the human body: meta-analysis of microbial community structures in human microbiome datasets. PLoS Comput. Biol. 9, e1002863 (2013).
51. Gobet, A., Quince, C. & Ramette, A. Multivariate cutoff level analysis (MultiCoLA) of large community data sets. Nucleic Acids Res. 38, e155 (2010).
52. Langille, M. G. et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 31, 814-821 (2013).
53. Abubucker, S. et al. Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput. Biol. 8, e1002358 (2012).
54. Gevers, D. et al. The treatment-naive microbiome in new-onset Crohns disease. Cell Host Microbe 15, 382-392 (2014).
55. Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011).
56. Smialowski, P., Frishman, D. & Kramer, S. Pitfalls of supervised feature selection. Bioinformatics 26, 440-443 (2009).